R A Miller

In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.

J A Koutcher, J. Koutcher, J. Sessler, 1999, International journal of radiation oncology, biology, physics.

Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy.

J. Sessler, Richard A. Miller, R A Miller, 2000, Biochemical pharmacology.

Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.

R Timmerman, M. Mehta, R. Timmerman, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model.

A. Yeung, P. Yock, J. Perlroth, 2001, Cardiovascular research.

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

J. Sessler, A. Harriman, S. Young, 1996, Proceedings of the National Academy of Sciences of the United States of America.